CCRP

Small Door Opens First Maryland Practice With New Bethesda Location

Retrieved on: 
Monday, March 18, 2024

Small Door Inc., a tech-enabled, membership-based veterinary care provider that operates under the brand Small Door Veterinary , today opened its first location in Maryland and will now be accepting new members at its state-of-the-art practice in Bethesda (10253 Old Georgetown Rd).

Key Points: 
  • Small Door Inc., a tech-enabled, membership-based veterinary care provider that operates under the brand Small Door Veterinary , today opened its first location in Maryland and will now be accepting new members at its state-of-the-art practice in Bethesda (10253 Old Georgetown Rd).
  • The new facility, located in the Wildwood Shopping Center, is the fourth location to open in the DMV (District of Columbia, Maryland, and Virginia), as Small Door continues to address a growing need for veterinary medicine amongst local pet owners.
  • The opening marks the eleventh Small Door location overall, continuing a steady expansion plan.
  • Launching at Wildwood Shopping Center continues our strategic rollout across the Greater Washington market,” explained Josh Guttman, Co-Founder and CEO of Small Door.

Bridging Cultures: Boao Forum's Sub-Forum on Religious Harmony Sparks Global Buddhist Dialogue

Retrieved on: 
Monday, April 1, 2024

QIONGHAI, China, April 1, 2024 /PRNewswire/ -- The Sub-forum on Religious Harmony and Mutual Learning Among Civilizations took place at the Boao Forum for Asia (BFA) Annual Conference 2024 by March 29.

Key Points: 
  • QIONGHAI, China, April 1, 2024 /PRNewswire/ -- The Sub-forum on Religious Harmony and Mutual Learning Among Civilizations took place at the Boao Forum for Asia (BFA) Annual Conference 2024 by March 29.
  • The Minister of Religious Affairs of Cambodia, Chay Borin, attended the event as a special guest.
  • Let us remain steadfast in promoting harmonious development and cooperation between the East and the West as we move forward."
  • He highlighted the positive impact of Buddhist principles such as compassion, peace, the Middle Way, and consummate interfusion in addressing the shared challenges humanity faces today.

The Religious Sub-forum of BFA 2024 to Feature the First Roundtable Thought Event

Retrieved on: 
Thursday, March 28, 2024

QIONGHAI, China, March 28, 2024 /PRNewswire/ -- The Sub-forum on Religious Harmony and Mutual Learning Among Civilizations at the Boao Forum for Asia 2024 ("BFA 2024") is set to feature its first ever roundtable discussion on March 29th.

Key Points: 
  • QIONGHAI, China, March 28, 2024 /PRNewswire/ -- The Sub-forum on Religious Harmony and Mutual Learning Among Civilizations at the Boao Forum for Asia 2024 ("BFA 2024") is set to feature its first ever roundtable discussion on March 29th.
  • At the media conference, YIN SHUN highlighted the remarkable achievements of the past years.
  • The Buddhist Association of China has proudly hosted eight Boao Religious Sub-Forums, eight South China Sea Buddhist Roundtables, and the "Overseas Spreading and Influence of Chinese Chan Culture - Dahongshan Forum".
  • Since its inception in 2015, the religious sub-forum of BFA has completed eight sessions, attracting a distinctive lineup of esteemed guests representing many of the world's religions, Nobel laureates, nationally recognized scholars, and leading journalists.

The Religious Sub-forum of BFA 2024 to Feature the First Roundtable Thought Event

Retrieved on: 
Thursday, March 28, 2024

QIONGHAI, China, March 28, 2024 /PRNewswire/ -- The Sub-forum on Religious Harmony and Mutual Learning Among Civilizations at the Boao Forum for Asia 2024 ("BFA 2024") is set to feature its first ever roundtable discussion on March 29th.

Key Points: 
  • QIONGHAI, China, March 28, 2024 /PRNewswire/ -- The Sub-forum on Religious Harmony and Mutual Learning Among Civilizations at the Boao Forum for Asia 2024 ("BFA 2024") is set to feature its first ever roundtable discussion on March 29th.
  • The event sought to promote mutual learning between world religions and civilizations of the East and West through the "Boao Dialogue".
  • HARADA MITSUNORI commented, "I feel optimistic about future cultural exchanges between Buddhist communities in China and Japan, fostering bridges of understanding and camaraderie between our two nations."
  • The Buddhist Association of China has proudly hosted eight Boao Religious Sub-Forums, eight South China Sea Buddhist Roundtables, and the "Overseas Spreading and Influence of Chinese Chan Culture - Dahongshan Forum".

Lucas GC Limited (NASDAQ: LGCL) Harnesses AI and GPT Technologies to Drive Human Resources Services and ESG Compliance

Retrieved on: 
Thursday, March 7, 2024

According to market research firm Frost and Sullivan, Lucas is the largest technology-driven online agency-centric human resources management service provider in China based on PaaS.

Key Points: 
  • According to market research firm Frost and Sullivan, Lucas is the largest technology-driven online agency-centric human resources management service provider in China based on PaaS.
  • The Company has achieved significant growth in revenue and net profit by effectively combining AI technology with traditional industries.
  • Lucas has successfully incorporated its core technologies, particularly in AIGC and GPT, into operations resulting in achieving double revenue growth in 2023.
  • Not only does Lucas incorporate ESG principles into business operations and innovations but they're also guiding principles for Lucas' corporate values.

Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy

Retrieved on: 
Wednesday, March 6, 2024

Timothy Warbington, CEO of Creative Medical Technology Holdings, stated, "The FDA's Orphan Drug Designation for CELZ-101 underscores our commitment to developing groundbreaking therapies.

Key Points: 
  • Timothy Warbington, CEO of Creative Medical Technology Holdings, stated, "The FDA's Orphan Drug Designation for CELZ-101 underscores our commitment to developing groundbreaking therapies.
  • “The Orphan Drug Designation by the FDA highlights CELZ-101's potential to meet a significant unmet need in the prevention of allograft rejection during pancreatic islet cell transplantation which was recently approved by the FDA.
  • Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) is dedicated to progressing CELZ-101 through the necessary regulatory pathways, with the goal of transforming the therapeutic landscape for patients in need of islet transplantation.
  • This achievement underscores the company's dedication to leveraging the natural regenerative capabilities of the human body to create lasting health solutions.

RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs

Retrieved on: 
Tuesday, March 5, 2024

The overall evaluation will also include assessment of opaganib's efficacy against sub-chronic fibrosis and acute respiratory distress syndrome (ARDS) resulting from Sulfur Mustard exposure.

Key Points: 
  • The overall evaluation will also include assessment of opaganib's efficacy against sub-chronic fibrosis and acute respiratory distress syndrome (ARDS) resulting from Sulfur Mustard exposure.
  • "With the alarming increase in global geo-political instability, the opportunity to evaluate opaganib as a potential vital protective agent against chemical attack is inspiring.
  • "Opaganib is the first selective sphingosine kinase-2 (SPHK2) inhibitor investigational drug targeting sphingolipid metabolism to be evaluated as a chemical countermeasure.
  • Opaganib, a novel oral, small molecule pill with a five-year shelf-life, is easy to administer and distribute for use against potential chemical weapon attack, if approved by the FDA.

Schwarzman Animal Medical Center Officially Opens New "Paw-Fect" Institute for Surgical Care

Retrieved on: 
Monday, January 29, 2024

NEW YORK, Jan. 29, 2024 /PRNewswire/ -- As the world's largest veterinary teaching hospital dedicated to the advancement of veterinary medicine, Schwarzman Animal Medical Center (AMC) announces the completion of its new Denise and Michael Kellen Institute for Surgical Care, as part of the hospital's $125 million transformational center-wide expansion. Tripling the capacity with more than 7,000 square feet of state-of-the-art space, the new Surgical Institute was designed by architects Perkins & Will and now features five brand-new operating rooms, a minor procedure room, a recovery room separating dogs and cats, and a new Central Sterile Center. The new facility opened today, welcoming patients (dogs, cats, and other small animals) 7 days a week, 365 days a year. 

Key Points: 
  • "We are thrilled to officially open the doors to the new Denise and Michael Kellen Institute for Surgical Care and are grateful to our benefactors who made this a reality," said Helen Irving, RN, MBA, President & Chief Executive Officer of Animal Medical Center.
  • "Denise and I are honored to provide the funding needed to help make this new Institute for Surgical Care possible," said Michael Kellen, Animal Medical Center Supporter.
  • Later in 2024, the Animal Medical Center will see the opening of the newly expanded Emergency Room, Intensive Care Unit and Special Care Unit, with expected project completion in 2025.
  • To download photos of the new Denise and Michael Kellen Institute for Surgical Care, visit amcny.org/newsurgerycenter .

See How it's Done: Case Studies on Patient Experience Design, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, November 20, 2023

TORONTO, Nov. 20, 2023 /PRNewswire-PRWeb/ -- Designing clinical trials around the patient and their experience produces better trials, but what does that really mean, and how is it actually accomplished? How can you be sure you're collecting data of interest to patient communities? Many common strategies have minimal impact or inadvertently create new challenges for patients. If the trial doesn't work for patients in their everyday lives, then no recruitment or retention plan can guarantee your study will generate the data you need.

Key Points: 
  • In this free webinar, learn how to design trials with a patient experience approach.
  • The featured speakers will discuss how to consider data that is important to patient communities.
  • Attendees will examine a protocol for patient experience optimization and learn how to apply real-life examples to their study.
  • TORONTO, Nov. 20, 2023 /PRNewswire-PRWeb/ -- Designing clinical trials around the patient and their experience produces better trials, but what does that really mean, and how is it actually accomplished?

Bitget Marks Exclusive Listing of PLEXUS (PLX) Token: Propelling Cross-Chain DEX Aggregator to the Forefront

Retrieved on: 
Thursday, December 14, 2023

Bitget Marks Exclusive Listing of PLEXUS (PLX) Token: Propelling Cross-Chain DEX Aggregator to the Forefront

Key Points: 
  • Bitget Marks Exclusive Listing of PLEXUS (PLX) Token: Propelling Cross-Chain DEX Aggregator to the Forefront
    The issuer is solely responsible for the content of this announcement.
  • Bitget, a leading cryptocurrency exchange and Web3 company, proudly announces its exclusive listing of PLEXUS (PLX) token, positioning the platform as the premier gateway for the revolutionary Cross-chain DEX aggregator on its debut day.
  • PLEXUS stands out as a Cross-chain DEX aggregator, promising the fastest, most cost-efficient, and secure multi-step swaps across diverse blockchain networks and bridges—all within a single transaction.
  • By facilitating the debut of this revolutionary Cross-chain DEX aggregator, Bitget continues its commitment to fostering user-centric innovation and propelling the industry toward a more accessible and integrated future.